People · Operator
Named in public records as an officer, director or promoter · active 2014–2022 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Delfi Diagnostics, Inc. | — | Biotechnology | Series D+ | $365.9M | $235.7M | 2022 |
| RightCare Solutions, Inc. | — | Other Health Care | Seed | $8.7M | $99.1M | 2014 |
Peter Bach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Bach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Murphy | 1 | 15 |
| Rishi Gupta | 1 | 12 |
| Greg Yap | 1 | 8 |
| Dennis Podlesak | 1 | 6 |
| MICHAEL DYBBS | 1 | 5 |
| Eric Heil | 1 | 5 |
| Jesse Treu | 1 | 4 |
| Justin Kao | 1 | 4 |
| Richard Perlman | 1 | 4 |
| William Stevens | 1 | 3 |
| Richard E. Perlman | 1 | 3 |
| Victor Velculescu | 1 | 2 |
| Elizabeth Homans | 1 | 2 |
| Greg B. Yap | 1 | 1 |
| Justin B. Kao | 1 | 1 |
| Jennifer Buechel | 1 | 1 |
| Douglas Schenkel | 1 | 1 |
| Jacob Van Naarden | 1 | 1 |
| Jesse E. Treu | 1 | 1 |
| Nicholas Dracopoli | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.